boosting Oncology investigate with built-in KRAS Assay products and services and RAS Assays
from the fast evolving subject of oncology investigation, precise and productive mutation screening is vital for developing specific therapies. The KRAS solutions System plays a pivotal purpose With this landscape by offering thorough solutions for KRAS mutation profiling and analysis. KRAS mutations, present in around ninety five% of RAS-relevant